Compare RPID & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RPID | CPIX |
|---|---|---|
| Founded | 2006 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 84.8M | 92.3M |
| IPO Year | 2021 | 2007 |
| Metric | RPID | CPIX |
|---|---|---|
| Price | $1.66 | $7.66 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | ★ 222.2K | 114.5K |
| Earning Date | 05-08-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 2.78 | ★ 58.70 |
| EPS | N/A | ★ N/A |
| Revenue | $33,587,000.00 | ★ $42,010,949.00 |
| Revenue This Year | $19.12 | N/A |
| Revenue Next Year | $18.42 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 19.74 | 16.75 |
| 52 Week Low | $1.52 | $1.85 |
| 52 Week High | $4.94 | $8.45 |
| Indicator | RPID | CPIX |
|---|---|---|
| Relative Strength Index (RSI) | 38.58 | 56.06 |
| Support Level | N/A | $5.55 |
| Resistance Level | $2.18 | $8.27 |
| Average True Range (ATR) | 0.14 | 0.71 |
| MACD | -0.03 | -0.04 |
| Stochastic Oscillator | 20.59 | 73.94 |
Rapid Micro Biosystems Inc is a life sciences technology company. Its technology uses a sensitive camera and the natural autofluorescence of living cells to identify and quantify microbial growth faster and more accurately than the traditional method, which relies on the human eye. The company develops, manufactures, markets, and sells Growth Direct systems (Systems), proprietary consumables, laboratory information management system (LIMS) connection, and other software and services to address rapid microbial analysis used for quality control in the manufacture of pharmaceuticals, medical devices, and personal care products. Geographically, it generates maximum revenue from the United States, and the rest from Switzerland, Germany, Japan, and all other countries.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.